Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome
E Monreal, S Sainz de la Maza… - Neurology …, 2021 - AAN Enterprises
Objective To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome
E Monreal, SS de la Maza… - Neurology …, 2021 - research.birmingham.ac.uk
Objective: To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
[HTML][HTML] Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
E Monreal, S Sainz de la Maza… - Neurology …, 2021 - AAN Enterprises
Objective To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
[HTML][HTML] Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
E Monreal, SS de la Maza… - Neurology® …, 2021 - ncbi.nlm.nih.gov
Objective To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.
E Monreal, L Costa-Frossard… - Neurology (r) …, 2021 - europepmc.org
Objective To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
E Monreal, SS de la Maza… - Neurology (R) …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To determine the best method to measure intrathecal immunoglobulin (Ig) M
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …
synthesis (ITMS), a biomarker of worse prognosis in multiple sclerosis (MS). We compared …